Whole-genome approach implicates CD44 in cellular resistance to carboplatin.

Human genomics

Volumn 3, Issue 2, 2009, Pages 128-142

  Shukla, Sunita J ^a   Duan, Shiwei ^a   Wu, Xiaolin ^a   Badner, Judith A ^a   Kasza, Kristen ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; HERMES ANTIGEN; SMALL INTERFERING RNA;

ARTICLE; DOSE RESPONSE; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; HUMAN; HUMAN GENOME; METABOLISM; QUANTITATIVE TRAIT LOCUS; TUMOR CELL LINE;

ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENOME, HUMAN; HUMANS; QUANTITATIVE TRAIT LOCI; RNA, SMALL INTERFERING;

EID: 65249086733     PISSN: None     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/1479-7364-3-2-128     Document Type: Article

References (0)